Osamu Kurasawa

766 total citations
18 papers, 492 citations indexed

About

Osamu Kurasawa is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Osamu Kurasawa has authored 18 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Osamu Kurasawa's work include DNA and Nucleic Acid Chemistry (5 papers), Cancer therapeutics and mechanisms (4 papers) and Chemical Synthesis and Analysis (3 papers). Osamu Kurasawa is often cited by papers focused on DNA and Nucleic Acid Chemistry (5 papers), Cancer therapeutics and mechanisms (4 papers) and Chemical Synthesis and Analysis (3 papers). Osamu Kurasawa collaborates with scholars based in Japan, United States and Norway. Osamu Kurasawa's co-authors include Mitsuo Sekine, Kohji Seio, Takeshi Wada, Keizo Hirase, Nobuhiro Inatomi, Naoki Tarui, Atsushi Hasuoka, Yasuyoshi Arikawa, Haruyuki Nishida and Terufumi Takagi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Science Advances.

In The Last Decade

Osamu Kurasawa

17 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osamu Kurasawa Japan 12 274 153 75 69 49 18 492
F Lemoine France 11 335 1.2× 22 0.1× 118 1.6× 47 0.7× 22 0.4× 33 546
Xuchao Wang China 14 198 0.7× 176 1.2× 41 0.5× 6 0.1× 38 0.8× 41 503
Junhua Fan China 12 241 0.9× 127 0.8× 38 0.5× 5 0.1× 34 0.7× 27 469
Hideyuki Tanimura Japan 12 297 1.1× 34 0.2× 100 1.3× 47 0.7× 9 0.2× 16 574
Kevin Yang United States 14 229 0.8× 141 0.9× 47 0.6× 5 0.1× 23 0.5× 27 502
Sadaaki Inutsuka Japan 13 179 0.7× 36 0.2× 105 1.4× 53 0.8× 14 0.3× 21 445
Hiromi Muraoka Japan 10 229 0.8× 18 0.1× 29 0.4× 13 0.2× 25 0.5× 23 422
Mitsuhiro Kinoshita Japan 10 105 0.4× 181 1.2× 32 0.4× 9 0.1× 6 0.1× 25 328
Yang-Hui Huang Taiwan 12 302 1.1× 52 0.3× 29 0.4× 6 0.1× 19 0.4× 29 479

Countries citing papers authored by Osamu Kurasawa

Since Specialization
Citations

This map shows the geographic impact of Osamu Kurasawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Kurasawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Kurasawa more than expected).

Fields of papers citing papers by Osamu Kurasawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Kurasawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Kurasawa. The network helps show where Osamu Kurasawa may publish in the future.

Co-authorship network of co-authors of Osamu Kurasawa

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Kurasawa. A scholar is included among the top collaborators of Osamu Kurasawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Kurasawa. Osamu Kurasawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Iwai, Kenichi, Tadahiro Nambu, Yukie Kashima, et al.. (2021). A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery. Science Advances. 7(21). 19 indexed citations
2.
Kurasawa, Osamu, T. Miyazaki, Misaki Homma, et al.. (2020). Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent. Journal of Medicinal Chemistry. 63(3). 1084–1104. 16 indexed citations
3.
Tanaka, Yuta, Osamu Kurasawa, Michael G. Klein, et al.. (2020). Discovery of Novel Allosteric Inhibitors of Deoxyhypusine Synthase. Journal of Medicinal Chemistry. 63(6). 3215–3226. 19 indexed citations
4.
Tanaka, Yuta, Osamu Kurasawa, Michael G. Klein, et al.. (2020). New Series of Potent Allosteric Inhibitors of Deoxyhypusine Synthase. ACS Medicinal Chemistry Letters. 11(8). 1645–1652. 11 indexed citations
5.
Nakamura, Akito, Tadahiro Nambu, Shunsuke Ebara, et al.. (2018). Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response. Proceedings of the National Academy of Sciences. 115(33). E7776–E7785. 110 indexed citations
6.
Kurasawa, Osamu, Yuya Oguro, T. Miyazaki, et al.. (2017). Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones. Bioorganic & Medicinal Chemistry. 25(7). 2133–2147. 14 indexed citations
7.
Kurasawa, Osamu, Misaki Homma, Yuya Oguro, et al.. (2017). 2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase. Bioorganic & Medicinal Chemistry. 25(14). 3658–3670. 10 indexed citations
8.
Sano, Osamu, et al.. (2017). Using a biologically annotated library to analyze the anticancer mechanism of serine palmitoyl transferase (SPT) inhibitors. FEBS Open Bio. 7(4). 495–503. 8 indexed citations
9.
Kurasawa, Osamu, et al.. (2016). A novel CDC7-selective inhibitor TAK-931 with potent antitumor activity. European Journal of Cancer. 69. S34–S34. 2 indexed citations
10.
Nishida, Haruyuki, Atsushi Hasuoka, Yasuyoshi Arikawa, et al.. (2012). Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers. Bioorganic & Medicinal Chemistry. 20(12). 3925–3938. 42 indexed citations
11.
Arikawa, Yasuyoshi, Haruyuki Nishida, Osamu Kurasawa, et al.. (2012). Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (P-CAB). Journal of Medicinal Chemistry. 55(9). 4446–4456. 128 indexed citations
12.
Imamura, Shinichi, Osamu Kurasawa, Takashi Ichikawa, et al.. (2004). CCR5 antagonists as anti-HIV-1 agents. Part 2: Synthesis and biological evaluation of N-[3-(4-benzylpiperidin-1-yl)propyl]-N,N′-diphenylureas. Bioorganic & Medicinal Chemistry. 12(9). 2295–2306. 15 indexed citations
13.
Imamura, Shinichi, Yuji Ishihara, Osamu Kurasawa, et al.. (2004). CCR5 Antagonists as Anti-HIV-1 Agents. 1. Synthesis and Biological Evaluation of 5-Oxopyrrolidine-3-carboxamide Derivatives. Chemical and Pharmaceutical Bulletin. 52(1). 63–73. 31 indexed citations
14.
15.
Sekine, Mitsuo, et al.. (2000). Synthesis and Properties of Oligodeoxynucleotides Incorporating a Conformationally Rigid Uridine Unit Having a Cyclic Structure at the 5‘-Terminal Site. The Journal of Organic Chemistry. 65(12). 3571–3578. 21 indexed citations
16.
Sekine, Mitsuo, Osamu Kurasawa, Koh‐ichiroh Shohda, Kohji Seio, & Takeshi Wada. (2000). Synthesis and Properties of Oligonucleotides Having a Phosphorus Chiral Center by Incorporation of Conformationally Rigid 5‘-Cyclouridylic Acid Derivatives. The Journal of Organic Chemistry. 65(20). 6515–6524. 28 indexed citations
17.
Sekine, Mitsuo, et al.. (1999). Synthesis of Artificially Bent Oligonucleotides by Incorporation of Conformationally Rigid 5′-Cyclouridylic Acid Derivatives. Nucleosides and Nucleotides. 18(6-7). 1163–1168.
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Lemoine Breakdown of academic impact, for papers by Xuchao Wang Breakdown of academic impact, for papers by Junhua Fan Breakdown of academic impact, for papers by Hideyuki Tanimura Breakdown of academic impact, for papers by Kevin Yang Breakdown of academic impact, for papers by Sadaaki Inutsuka Breakdown of academic impact, for papers by Hiromi Muraoka Breakdown of academic impact, for papers by Mitsuhiro Kinoshita Breakdown of academic impact, for papers by Yang-Hui Huang
Rankless by CCL
2026